Arthur O. Tzianabos
2017
In 2017, Arthur O. Tzianabos earned a total compensation of $2.4M as President and Chief Executive Officer at Homology Medicines.
Compensation breakdown
| Non-Equity Incentive Plan | $168,920 |
|---|---|
| Option Awards | $1,815,320 |
| Salary | $422,300 |
| Total | $2,406,540 |
Tzianabos received $1.8M in option awards, accounting for 75% of the total pay in 2017.
Tzianabos also received $168.9K in non-equity incentive plan and $422.3K in salary.
Rankings
In 2017, Arthur O. Tzianabos' compensation ranked 4,622nd out of 14,666 executives tracked by ExecPay. In other words, Tzianabos earned more than 68.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,622 out of 14,666 | 69th |
Division Manufacturing | 1,628 out of 5,772 | 72nd |
Major group Chemicals And Allied Products | 472 out of 2,075 | 77th |
Industry group Drugs | 364 out of 1,731 | 79th |
Industry Pharmaceutical Preparations | 289 out of 1,333 | 78th |
Source: SEC filing on April 25, 2019.
Tzianabos' colleagues
We found one more compensation record of an executive who worked with Arthur O. Tzianabos at Homology Medicines in 2017.
2017
Albert Seymour
Homology Medicines